Arthrosamid Hydrogel Easing Osteoarthritis After Meniscectomy
Post-meniscectomy knee pain and osteoarthritis pose ongoing challenges due to loss of the meniscus's cushioning function. Arthrosamid, a biocompatible polyacrylamide hydrogel injection, offers a novel, minimally invasive option to alleviate chronic symptoms by supplementing shock absorption and improving joint movement. Studies demonstrate its safety and effectiveness, particularly in patients with milder OA and suitable health profiles. Led by Professor Paul Lee at the London Cartilage Clinic, expert multidisciplinary care tailors treatment plans combining Arthrosamid with physiotherapy to optimize joint health and mobility. While not curative, Arthrosamid represents a promising adjunct for managing persistent post-surgery knee discomfort. Patient evaluation and personalized approaches remain essential for best outcomes.
